Natural Killer Cells Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies), By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others), By End User (Hospitals & Clinics, Academic & Research Institutions, Others), By Region

December 2022 | 111 pages | ID: N49081F0C6DFEN
TechSci Research

Abstracts

The global natural killer cells therapeutics market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to growing patient pool suffering from various chronic diseases such as cancer, cardiovascular diseases, diabetes, among others. According to global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer being the most prevalent types. This has increased the demand for effective treatment options for finding a cure for cancer, thereby driving the growth of global natural killer cells therapeutics market. Additionally, growing focus of biotechnology & pharmaceutical companies and academic & research institutions across the globe for developing cost effective and potent treatments for different chronic diseases is expected to create lucrative opportunities for the market growth in the coming years. These companies and research organizations are conducting research & development activities and launching clinical trials in search of a potential natural killer cells therapeutics solution for different chronic and acute diseases. According, to clinicaltrials.gov, there are around 199 clinical trials related to natural killer cells are in some phase of development worldwide.

Application of the Natural Killer Cells in Treatment of Critical Diseases

Increasing application of natural killer cells for the treatment of various disease including liver diseases, infections, cancer, among others is expected to drive the growth of global natural killer cells therapeutics market in the forecast period. In addition to this, the natural killer cells play a pivotal role in the immune surveillance of tumor. This in turn is leading to the widespread adoption of natural killer cells therapeutics across the world. Besides, natural killer cells have specific attaching ability and ability to discard stressed cells. All these benefits associated with natural killer cells is expected to drive the growth of global natural killer cells therapeutics market during the forecast period.

Rise in Awareness about Immunotherapies

The prevalence of cancer has increased worldwide over the years and the available treatment options are not that efficient since a lot of instances of reoccurrence of tumours has been witnessed, arising the need for development of an effective and permanent treatment. Immunotherapies have gained much attention in recent years to treat different malignancies. Among all the immunotherapies, CAR –T cell therapies have been studied and were used but have various limitations that led to the development of natural killer (NK) cell therapies. Growing the awareness among the population about various immunotherapies and increase in research and development of bi-specific antibody for engaging natural killer cells to eliminate tumor cells are driving the global natural killer (NK) cell therapeutics market.

Market Segmentation

The global natural killer cells therapeutics market can be segmented by type, by application, by end use, and by region. Based on type, the market can be segmented into natural killer cell therapies and natural killer cell directed antibodies. Based on application, the market can be differentiated into cancer, gastrointestinal diseases, immunoproliferative disorders, and others. Based on end user, the market can be categorized into hospitals & clinics, academic & research institutions, and others. Regionally, North America dominated the global natural killer cells therapeutics market followed by Europe, Asia Pacific, South America, and Middle East & Africa region. In terms of countries, United States dominated the global natural killer cells therapeutics market in 2021 and is expected to maintain its dominance during the forecast period on account of growing prevalence of different chronic diseases in the country. According to the global cancer observatory, around 2,281,658 new cancer cases were reported in the United States in 2020.

Market Players

Affimed N.V., Century Therapeutics, Inc., Celularity Inc., Cytovac A/S, Dragonfly Therapeutics, Inc., Fate Therapeutics, Inc., Gamida Cell Ltd., ImmunityBio, Inc., Innate Pharma SA , Nkarta, Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited , VaxCell Biotherapeutics Co., Ltd., Acepodia Inc., Glycostem Therapeutics B.V., among others are some of the leading players operating in the global natural killer cells therapeutics market.

Report Scope:

In this report, global natural killer cells therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Natural Killer Cells Therapeutics Market, By Type:
• Natural Killer Cell Therapies
• Natural Killer Cell Directed Antibodies
• Natural Killer Cells Therapeutics Market, By Application:
• Cancer
• Gastrointestinal Diseases
• Immunoproliferative Disorders
• Others
• Natural Killer Cells Therapeutics Market, By End User:
• Hospitals & Clinics
• Academic & Research Institutions
• Others
• Natural Killer Cells Therapeutics Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Turkey
• Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Natural Killer Cells Therapeutics Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. IMPACT OF COVID-19 ON GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET

5. VOICE OF CUSTOMER

6. CLINICAL TRIAL ANALYSIS

7. GLOBAL NATURAL KILLER CELLS THERAPEUTICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Type (Natural Killer Cell Therapies v/s Natural Killer Cell Directed Antibodies)
  7.2.2. By Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, Others)
  7.2.3. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
  7.2.4. By Region
  7.2.5. By Company (2021)
7.3. Market Map

8. NORTH AMERICA NATURAL KILLER CELLS THERAPEUTICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Type
  8.2.2. By Application
  8.2.3. By End User
  8.2.4. By Country
8.3. North America: Country Analysis
  8.3.1. United States Natural Killer Cells Therapeutics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Type
      8.3.1.2.2. By Application
      8.3.1.2.3. By End User
  8.3.2. Canada Natural Killer Cells Therapeutics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Type
      8.3.2.2.2. By Application
      8.3.2.2.3. By End User
  8.3.3. Mexico Natural Killer Cells Therapeutics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Type
      8.3.3.2.2. By Application
      8.3.3.2.3. By End User

9. EUROPE NATURAL KILLER CELLS THERAPEUTICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Type
  9.2.2. By Application
  9.2.3. By End User
  9.2.4. By Country
9.3. Europe: Country Analysis
  9.3.1. France Natural Killer Cells Therapeutics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Type
      9.3.1.2.2. By Application
      9.3.1.2.3. By End User
  9.3.2. Germany Natural Killer Cells Therapeutics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Type
      9.3.2.2.2. By Application
      9.3.2.2.3. By End User
  9.3.3. United Kingdom Natural Killer Cells Therapeutics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Type
      9.3.3.2.2. By Application
      9.3.3.2.3. By End User
  9.3.4. Italy Natural Killer Cells Therapeutics Market Outlook
    9.3.4.1. Market Size & Forecast
      9.3.4.1.1. By Value
    9.3.4.2. Market Share & Forecast
      9.3.4.2.1. By Type
      9.3.4.2.2. By Application
      9.3.4.2.3. By End User
  9.3.5. Spain Natural Killer Cells Therapeutics Market Outlook
    9.3.5.1. Market Size & Forecast
      9.3.5.1.1. By Value
    9.3.5.2. Market Share & Forecast
      9.3.5.2.1. By Type
      9.3.5.2.2. By Application
      9.3.5.2.3. By End User

10. ASIA-PACIFIC NATURAL KILLER CELLS THERAPEUTICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Type
  10.2.2. By Application
  10.2.3. By End User
  10.2.4. By Country
10.3. Asia-Pacific: Country Analysis
  10.3.1. China Natural Killer Cells Therapeutics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Type
      10.3.1.2.2. By Application
      10.3.1.2.3. By End User
  10.3.2. India Natural Killer Cells Therapeutics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Type
      10.3.2.2.2. By Application
      10.3.2.2.3. By End User
  10.3.3. Japan Natural Killer Cells Therapeutics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Type
      10.3.3.2.2. By Application
      10.3.3.2.3. By End User
  10.3.4. South Korea Natural Killer Cells Therapeutics Market Outlook
    10.3.4.1. Market Size & Forecast
      10.3.4.1.1. By Value
    10.3.4.2. Market Share & Forecast
      10.3.4.2.1. By Type
      10.3.4.2.2. By Application
      10.3.4.2.3. By End User
  10.3.5. Australia Natural Killer Cells Therapeutics Market Outlook
    10.3.5.1. Market Size & Forecast
      10.3.5.1.1. By Value
    10.3.5.2. Market Share & Forecast
      10.3.5.2.1. By Type
      10.3.5.2.2. By Application
      10.3.5.2.3. By End User

11. SOUTH AMERICA NATURAL KILLER CELLS THERAPEUTICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Type
  11.2.2. By Application
  11.2.3. By End User
  11.2.4. By Country
11.3. South America: Country Analysis
  11.3.1. Brazil Natural Killer Cells Therapeutics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Type
      11.3.1.2.2. By Application
      11.3.1.2.3. By End User
  11.3.2. Argentina Natural Killer Cells Therapeutics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Type
      11.3.2.2.2. By Application
      11.3.2.2.3. By End User
  11.3.3. Colombia Natural Killer Cells Therapeutics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Type
      11.3.3.2.2. By Application
      11.3.3.2.3. By End User

12. MIDDLE EAST AND AFRICA NATURAL KILLER CELLS THERAPEUTICS MARKET OUTLOOK

12.1. Market Size & Forecast
  12.1.1. By Value
12.2. Market Share & Forecast
  12.2.1. By Type
  12.2.2. By Application
  12.2.3. By End User
  12.2.4. By Country
12.3. MEA: Country Analysis
  12.3.1. South Africa Natural Killer Cells Therapeutics Market Outlook
    12.3.1.1. Market Size & Forecast
      12.3.1.1.1. By Value
    12.3.1.2. Market Share & Forecast
      12.3.1.2.1. By Type
      12.3.1.2.2. By Application
      12.3.1.2.3. By End User
  12.3.2. Saudi Arabia Natural Killer Cells Therapeutics Market Outlook
    12.3.2.1. Market Size & Forecast
      12.3.2.1.1. By Value
    12.3.2.2. Market Share & Forecast
      12.3.2.2.1. By Type
      12.3.2.2.2. By Application
      12.3.2.2.3. By End User
  12.3.3. UAE Natural Killer Cells Therapeutics Market Outlook
    12.3.3.1. Market Size & Forecast
      12.3.3.1.1. By Value
    12.3.3.2. Market Share & Forecast
      12.3.3.2.1. By Type
      12.3.3.2.2. By Application
      12.3.3.2.3. By End User
  12.3.4. Turkey Natural Killer Cells Therapeutics Market Outlook
    12.3.4.1. Market Size & Forecast
      12.3.4.1.1. By Value
    12.3.4.2. Market Share & Forecast
      12.3.4.2.1. By Type
      12.3.4.2.2. By Application
      12.3.4.2.3. By End User
  12.3.5. Egypt Natural Killer Cells Therapeutics Market Outlook
    12.3.5.1. Market Size & Forecast
      12.3.5.1.1. By Value
    12.3.5.2. Market Share & Forecast
      12.3.5.2.1. By Type
      12.3.5.2.2. By Application
      12.3.5.2.3. By End User

13. MARKET DYNAMICS

13.1. Drivers
13.2. Challenges

14. MARKET TRENDS & DEVELOPMENTS

15. COMPETITIVE LANDSCAPE

15.1. Affimed N.V.
15.2. Century Therapeutics, Inc.
15.3. Celularity Inc.
15.4. Cytovac A/S
15.5. Dragonfly Therapeutics, Inc.
15.6. Fate Therapeutics, Inc.
15.7. Gamida Cell Ltd.
15.8. ImmunityBio, Inc.
15.9. Innate Pharma SA
15.10. Nkarta, Inc.
15.11. Sanofi S.A.
15.12. Takeda Pharmaceutical Company Limited
15.13. VaxCell Biotherapeutics Co., Ltd.
15.14. Acepodia Inc.
15.15. Glycostem Therapeutics B.V.

16. STRATEGIC RECOMMENDATIONS